E-DRUG: UU-WHO summer course programme in Utrecht, the Netherlands
-------------------------------------------------------------------------------------------------------
Dear E-Druggers,
This summer, the Division of Pharmacoepidemiology and Clinical Pharmacology at Utrecht University, the Netherlands (the WHO CC for Pharmaceutical Policy and Regulation), offers you again three challenging international summer courses:
6-10 July 2015 - Pharmacoepidemiology & Drug safety
13-17 July 2015 - Pharmaceutical Policy Analysis (in collaboration with WHO)
20-24 July 2015 - Pharmacoeconomics
More detailed information can be found below and on the summer school website
<http://www.utrechtsummerschool.nl>
All courses will cover the key issues in each field and focus on the most important research methods used. All course teachers have extensive expertise in their field.
A few scholarships are available for the Pharmaceutical Policy Analysis course. These scholarships include course fee, basic student housing as described on the summer school website and a small daily allowance to cover expenses for food and local transport. International travel is at the expense of the applicant or his/her institution.
If you wish to apply for a scholarship, please do so before 20 April 2015 by sending an application letter including motivation plus CV to our course assistant Winnie de Bruijn
<pharm.summercourses@gmail.com>
All applicants will be notified by 1 May 2015.
Supplementary, there is a cultural and social programme arranged for participants to make sure that they experience the best of Utrecht.
Please feel free to share this information with others who might be interested to attend. We look forward to welcoming you or them in Utrecht this summer!
Warm wishes,
Aukje Mantel,
Managing Director WHO CC for Pharmaceutical Policy & Regulation
M7 Pharmaceutical Policy Analysis (13-17 July 2015)
Medicines are among the most regulated products in society. From the earliest pre-clinical stages onward, policy makers want to foster the development of safe, effective and affordable medicines for patients in need of pharmacotherapy. When a drug reaches the market, it is the beginning of a process of complex interactions between patients, prescribers, insurers, pharmaceutical companies and governments. Furthermore, the inequity in access to medicines is still a defining characteristic of the global pharmaceutical market place.
The aim of the course is to give students insight into current developments in pharmaceutical policy making as well to give a better understanding of the methods available for analysing the effects of policy interventions. As a collaborator on this course, the World Health Organization will provide faculty for several of the sessions.
You will experience an intensive programme covering the following topics: Pharmaceutical Policy Analysis issues and methods; current challenges in drug innovation; universal health coverage; regulatory issues and challenges; country profiles; policy and politics; synthesis, case studies & public health
Course directors: Prof. Dr. Bert Leufkens, Dr. Kees de Joncheere (World Health Organization) and Dr. Aukje Mantel.
M8 Pharmacoepidemiology & Drug Safety (6-10 July 2015)
With the prospect that innovative drug therapies will be introduced in the coming years, society demands new approaches and concepts for comparative risk/benefit evaluation. Assessment of safety and risk management of different drug therapies is done in the framework of observational epidemiological studies (proof of ‘safety’, proof of ‘effectiveness’). This is the logical next step after randomized clinical trials, which are designed to provide evidence of a drugs ‘efficacy’.
The course will cover key issues in pharmacoepidemiologic and drug safety research. Special topics include databases and molecular pharmacoepidemiology. Students will learn about the typical problems (e.g. confounding by indication, rare side effects) and approaches to deal with these problems in the practice of pharmacoepidemiology.
You will experience an intensive programme covering the following topics: Study Design and Methods; Confounding and other biases; Methods in drug safety research; Drug Safety and Risk Management; Overview of Pharmacoepidemiological databases; Molecular Pharmacoepidemiology; Drug utilization research; Synthesis, case studies & public health
Course directors: Prof. dr. O.H. Klungel and Prof. dr. T.P. van Staa
M14 Pharmacoeconomics (20-24 July 2015)
Today's society is confronted with ever increasing health care costs. One of the factors is the cost of drug innovations. Diseases waiting for therapeutic solutions are complicated and multifactorial in nature. As a result, drug innovation has become even more complex leading to high tech and therefore high cost solutions. The question arises, what is the added value of such high cost innovations and how can it be determined when both benefit and harm are considered. Health economics, and more specific pharmacoeconomics, aims to provide a neutral scientific approach to this challenge.
This course aims to provide a broad perspective of the field, including a variety of subjects from views of the different stakeholders to more in depth methodological approaches, illustrated with examples and exercises.
You will experience an intensive programme covering the following topics: Pharmacoeconomic techniques; Study designs and methods; Critical appraisal of pharmacoeconomic studies; The (im)possibilities of the use of HTA and pharmacoeconomics in regulatory decisions; The economics of personalized medicine
Course directors: Dr. A. Hovels, Dr. G.W.J. Frederix, Prof. dr. J.A.M. Raaijmakers
General information for all courses
Target groups
(Post)graduates and professionals within governments, NGOs, industry, universities with a basic knowledge public health/medicine who have an interest in the policy aspects of pharmaceuticals, pharmacoepidemiology and/or pharmacoeconomics.
Fee and combinations
€950,- per course (including course materials + lunches + course dinner, excluding housing). Combination fee for two courses is €1500,- (excluding housing), combination fee for all three courses combined is €1950,- (excluding housing)
Deadline for application
1 June 2015, see
<http://www.utrechtsummerschool.nl>
(information re summer school, course registration and housing)
More information
Course assistant: Winnie de Bruijn
<pharm.summercourses@gmail.com>
Aukje Mantel-Teeuwisse, PhD
Director School of Pharmacy, Utrecht University
http://students.uu.nl/beta/farmacie-m.
Managing director WHO Collaborating Centre for Pharmaceutical Policy and Regulation
<https://solismail.uu.nl/owa/redir.aspx?C=ba448a83a7cc4540b0c669454cab9c8b&URL=http%3A%2F%2Fwww.pharmaceuticalpolicy.nl%2F>\)
Division Pharmacoepidemiology & Clinical Pharmacology
PO Box 80 082 | 3508 TB Utrecht
The Netherlands | Tel: +31 6 22736017 or +31 30 253 7324 (secretariat)
Visiting address:
David de Wied building | Universiteitsweg 99 | 3584 CG Utrecht | the Netherlands
"Mantel-Teeuwisse, A.K. (Aukje)" <A.K.Mantel@uu.nl>